Carl Burgman Achieves Remission From Multiple Myeloma via CAR-NK Trial
Carl Burgman achieved long-term remission from high-resistant multiple myeloma after receiving a single infusion of engineered natural killer cells in a Phase I clinical trial, Health Usnews reported. Donor Cells … Read More